Bone Marrow Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammatory Reactions in Macrophages and Endothelial Cells

Background. Systemic inflammatory response syndrome (SIRS) accompanied by trauma can lead to multiple organ dysfunction syndrome (MODS) and even death. Early inhibition of the inflammation is necessary for damage control. Bone marrow mesenchymal stem cells (BMSCs), as a novel therapy modality, have...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mediators Inflamm
Main Authors: Li, Dequan, Wang, Cong, Chi, Chuang, Wang, Yuanyuan, Zhao, Jing, Fang, Jun, Pan, Jingye
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746395/
https://ncbi.nlm.nih.gov/pubmed/27057093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/2631439
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares